Shares of Complete Genomics Inc. (NASDAQ: GNOM), a life sciences company engaged in the development and commercialization of a deoxyribonucleic acid (DNA) sequencing platform, are continuing to rally.
Shares of Complete Genomics Inc. (NASDAQ: GNOM), a life sciences company engaged in the development and commercialization of a deoxyribonucleic acid (DNA) sequencing platform, are continuing to rally.